A GlobalData analyst has warned that Trump's second term could see major changes in US healthcare, and RFK could rock the ...

Becker's asked pharmacy executives from hospitals and health systems across the U. S. to share their team or system's biggest achievement this year.

The US trade group Pharmaceutical Research and Manufacturers of America (PhRMA) today launched new advertisements urging ...

States may be getting ready to crack down even harder on pharmacy benefit managers. The National Association of Insurance ...

Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

The story was too "uncomfortable" for local MSM to cover so instead our progressive local news outlet blame shifts pharmacy ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Among the gains in the contract are the elimination of two-tier wage scale and an increased health care bonus.

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Craig Hettenbach, an analyst from Morgan Stanley, maintained the Hold rating on GoodRx Holdings (GDRX – Research Report). The associated ...